What is BPC-157?

BPC-157 is a pentadecapeptide composed of 15 amino acids. It is part of the body protection compound (BPC) isolated from human gastric juice.

In various preclinical studies, it has been observed to accelerate the recovery of muscles, tendons and ligaments. Experimental data suggest that it may help protect organs and have an effect on the gastric mucosa.

Systemic action has been reported in the gastrointestinal tract, with effects in animal models for conditions such as leaky gut, irritable bowel syndrome, gastrointestinal spasms, and Crohn's disease. Some studies report a potential analgesic effect.

In laboratory conditions, BPC-157 has been associated with increased collagen and reticulin formation, as well as angiogenesis, while also increasing macrophage and fibroblast activity. These observations suggest that the peptide may have potential applications as a tool in the study of wound healing processes.

Potential benefits

BPC-157 is being studied for its possible effects on:

• Healing of injuries – tendons, muscles, joints, bones.

• Chronic inflammation – reduces pain and inflammatory reactions.

• Gastrointestinal protection – supports the mucous membrane and protects against ulcers.

• Improved circulation – stimulates the growth of new vessels and tissue nutrition.

• Surgical recovery – accelerates wound healing after surgeries.

• Organ protection – data on beneficial effects on the liver, heart and nervous system.

• Joint and bone health – supports cartilage and bone tissue.

• Anti-inflammatory effect – reduces the overall inflammatory response.

• Faster recovery in athletes – shortens regeneration time after heavy training.

Scientific data

BPC-157 has been primarily studied in preclinical models, where a wide range of potential applications have been identified.

• In the field of orthopedics, effects such as accelerated healing of tendons, ligaments and muscle tears, as well as stimulation of osteogenesis in bone injuries, have been reported.

• In gastroenterology, the peptide shows protective effects on the gastric and intestinal mucosa, including reduction of ulcers, recovery in colitis, and limitation of damage from nonsteroidal anti-inflammatory drugs.

• In cardiology, experiments indicate protective effects in ischemic myocardial damage, improved angiogenesis and local blood supply.

• Data from neurological models show potential to support peripheral nerve regeneration and reduce neurotoxic damage.

• In addition, anti-inflammatory properties have been observed in arthritis with a reduction in pain and swelling.

Dosage and administration

In the scientific literature, doses of 250–500 mcg per day are most commonly found.

At 5 mg + 3 ml bacteriostatic water: 1.67 mg/ml → 0.12 to 0.3 ml daily

At 10 mg + 3 ml bacteriostatic water: 3.33 mg/ml → 0.06 to 0.15 ml daily

Example values for 5 mg:

• 0.1 ml = 167 mcg

• 0.2 ml = 333 mcg

• 0.3 ml = 500 mcg

• 0.5 ml = 830 mcg

Example values for 10 mg:

• 0.1 ml = 333 mcg

• 0.2 ml = 667 mcg

• 0.3 ml = 1000 mcg

• 0.5 ml = 1667 mcg

Application in sports

BPC-157 is banned by WADA for use by athletes because it can:

• accelerate recovery after exercise

• restore tendons and joints

• improve tissue regeneration

• increase endurance through better blood supply

Possible side effects

BPC-157 is considered relatively safe. Reported reactions are rare, mild, and associated with high doses:

• mild stomach discomfort or nausea

• redness or pain at the injection site